Paul Donnelly

The Donnelly research group focuses on the application of synthetic organic/inorganic chemistry to biology and materials science. Their multidisciplinary research approach is focussed on the application of coordination chemistry to metal-based drugs and the study of metal ions in biological systems. In addition, they are interested in the role of metal ions in biology including the development of metal-based radiopharmaceuticals for imaging and therapy of cancer. Other projects focus on the development of metal-based drugs for the treatment and diagnosis of Alzheimer's disease.

The group is multidisciplinary in its approach.

Techniques include: inorganic/organic synthesis, Schlenk lines for anaerobic preparative work and the application of a wide range of analytical approaches including multinuclear NMR, mass spectrometry, electronic and fluorescent spectroscopy, EPR, HPLC, UV-vis, electrochemistry and X-ray crystallography.

Paul Donnelly Bio

Paul Donnelly is a Lecturer with the School of Chemistry and relocated his research activities to the Bio21 Institute in 2004. Attaining his BSc Hons and PhD from the University of Western Australia, Paul undertook postdoctoral research at Oxford University prior to returning to Australia to take up a role as ARC Research Fellow. In 2005 he was awarded the Kaye Merlin Brutton Prize for Research in Cancer. Paul was also the recipient of the 2007 Selby Research Award.